They identified RNA binding protein NOVA-1 (NOVA1) to be a marker distinguishing astrocytoma with oligodendrogliomas and heat shock protein beta 1 (HSPB1) as a predictive marker for poor prognosis for GBM15. Here, HSPB1 is linked to astrocytoma (excluding glioblastoma).